Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
570K
-
Shares change
-
-11.3K
-
Total reported value, excl. options
-
$148M
-
Value change
-
-$2.9M
-
Number of buys
-
8
-
Number of sells
-
-3
-
Price
-
$258.77
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q4 2023
15 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q4 2023.
BIOGEN INC. - Common Stock (BIIB) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 570K shares
of 147M outstanding shares and own 0.39% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (16.3M shares), VANGUARD GROUP INC (14.4M shares), BlackRock Inc. (14.2M shares), STATE STREET CORP (6.95M shares), T. Rowe Price Investment Management, Inc. (5.36M shares), WELLINGTON MANAGEMENT GROUP LLP (5.32M shares), JPMORGAN CHASE & CO (5.07M shares), GEODE CAPITAL MANAGEMENT, LLC (3.31M shares), Invesco Ltd. (1.81M shares), and Clearbridge Investments, LLC (1.68M shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.